Andrew Baron

Andrew Baron is the Scientific Director of the Bioanalytical Department at RoukenBio, a position held since 2021, where they oversee the development of bioassays and advanced binding technologies for drug characterization. Previously, they worked as a Senior Scientist at BioOutsource, managing complex bioanalytical studies and ensuring regulatory compliance. Andrew also served as the Head of Research and Development at Antibody Analytics, focusing on innovative biosimilar testing technologies. They earned a PhD in Neuroscience and a First Class Honours degree in Pharmacology from Newcastle University, where they further specialized with a Master’s in Medical and Molecular Biosciences.